Prime Medicine, Inc. (PRME) Operating income 2020–2025
Prime Medicine, Inc. (PRME) annual operating income history from SEC filings — each fiscal year as reported.
-$208.3MFY2025 · since FY2020: -$932,000 → -$208.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$208.3M | -2.9% |
| FY2024 | -$202.5M | +1.1% |
| FY2023 | -$204.8M | -75.7% |
| FY2022 | -$116.5M | -38.0% |
| FY2021 | -$84.5M | -8963.7% |
| FY2020 | -$932,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice